GIC
GILD icon

Generali Investments CEE’s Gilead Sciences GILD Stock Holding History

Generali Investments CEE’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.81M Hold
53,896
– – 0.32% 92
2026
Q1 		$7.51M Hold
53,896
– – 0.39% 74
2025
Q4 		$6.62M Sell
53,896
-2,729
-5% -$332K 0.47% 59
2025
Q3 		$6.29M Sell
56,625
-1,879
-3% -$214K 0.48% 63
2025
Q2 		$6.49M Sell
58,504
-14,964
-20% -$1.59M 0.53% 48
2025
Q1 		$8.23M Sell
73,468
-6,982
-9% -$720K 0.77% 26
2024
Q4 		$7.43M Buy
+80,450
New +$7.24M 0.77% 27

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Generali Investments CEE's GILD Position: Q2 2026 in Review

Generali Investments CEE held its Gilead Sciences (GILD) position steady in Q2 2026 at 53,896 shares worth $6.81M. The position accounts for 0.32% of the portfolio, ranked #92.

Generali Investments CEE first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.23M in Q1 2025. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Generali Investments CEE held 53,896 shares of Gilead Sciences worth $6.81M as of Q2 2026.
  • Generali Investments CEE left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.32% of Generali Investments CEE's portfolio in Q2 2026, its #92 holding.
  • Generali Investments CEE first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Generali Investments CEE's Gilead Sciences position peaked at $8.23M in Q1 2025.
  • 2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.